Vulnuzan® (Vulnusan®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspointment for topical and topical application
Composition:

Component name

Content, g


in 100 grams

in 45 grams

Active substance

Lake of Pomorie

12,000

5,400

Lye (Stabilized Lye



"Solilug")



Excipients

Cage plants of ordinary seeds

20,000

9,000

butter



(Castor oil)



Carmellose sodium

3,000

1,350

Lanolin

32,000

14,400

Sodium benzoate

0,500

0,225

Purified water

32,500

14,625

Description:
Homogeneous ointment from light yellow to yellow with a specific smell.
Pharmacotherapeutic group:Anti-inflammatory agent of natural origin for topical application
ATX: & nbsp
  • Other preparations for the treatment of skin diseases
    • Pharmacodynamics:The preparation of natural origin from the alkali of Pomorie Lake contains a number of macro and microelements important for the human body-magnesium chloride and sulphate, sodium chloride, potassium, calcium, iron, chlorine, bromine, selenium, molybdenum, copper, manganese, zinc, iodine, bismuth, silicium, titanium, arsenic, beryllium, aluminum sulphate, colloidal substances, acids and other organic compounds. Anti-inflammatory and disinfecting action, inhibiting pathogenic bacterial flora, stimulates protective immunobiological response - phagocytosis and antibody formation, stimulates the regeneration of tissues and epithelization of wound surfaces.
    Indications:In the complex treatment of purulent wounds of various origins: infected, surgical superficial purulent processes, including pararectal and postinjection abscesses, trophic ulcers, posttraumatic and atherosclerotic wounds, medical maceration of the skin, ulceration of the skin in Buerger's disease, varicose ulcers, cervical erosion, mammary gland.
    Contraindications:Hypersensitivity to the components of the drug, pregnancy, children's age (up to 12 years).
    Carefully:

    Pregnancy and lactation:
    The use of the drug during pregnancy is contraindicated.
    During the period of breastfeeding the drug can be used in recommended doses. Consultation of the doctor is necessary.
    Dosing and Administration:
    Locally, externally.
    The ointment is applied directly to the wound or gauze in an amount sufficient to cover the wound surface, a layer 2-3 mm thick.
    Single dose - no more than 10 - 15 g of ointment (with deep abscesses). At the beginning of the treatment, the ointment is applied daily, when the inflammatory process stops and the granulation tissue appears - every other day. When treating cracked nipples of the breast, ointment is applied several times a day after feeding the baby.Before the beginning of the next feeding, the preparation should be thoroughly washed off with warm boiled water. In the treatment of cervical erosion, a tampon with a drug applied to it is used, which is administered once a day, preferably in the evening, for 10-15 days.
    Side effects:Possible allergic reactions in the form of skin rash, hives, angioedema. There may be pain in the place of application of the drug in patients with varicose ulcers and skin lesions with Buerger's disease.
    Overdose:There have been no cases of overdose with the use of the drug.
    Interaction:Not described.
    Special instructions:
    - If necessary, you can use occlusive dressings.
    - The drug contains lanolin, which can cause local skin reactions (eg, contact dermatitis).
    - Cysts of common seed oil (castor oil) when applied topically can cause skin reactions.
    - Sodium benzoate can cause mild irritation when ingested into the eyes and mucous membranes, and so can cause slight irritation to the skin.
    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the ability to drive vehicles and engage in potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:
    Ointment for local and external use.


    Packaging:For 45 g of the drug in an aluminum tube. Each tube together with instructions for medical use is placed in a cardboard box.
    Storage conditions:
    In dry, the dark place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children!
    Shelf life:
    2 years.
    Shelf life after the opening of the tube: 1 month.
    Do not apply but the expiration date indicated on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:P N008924
    Date of registration:01.09.2011 / 13.02.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:Sopharma, AOSopharma, AO Bulgaria
    Manufacturer: & nbsp
    Representation: & nbspSOFARMA SA SOFARMA SA Bulgaria
    Information update date: & nbsp10.03.2017
    Illustrated instructions
      Instructions
      Up